Federal Trade Commission Votes to Close Investigation of Proposed Merger of Amerisource Health Corporation and Bergen Brunswig Corporation

For Release

After conducting a detailed investigation of the proposed merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, the Federal Trade Commission has voted to close the matter and to allow the merger to proceed without taking any enforcement action. A statement issued by the Commission discusses the reasons for its conclusion in this matter.

The Commission vote to close the investigation was 5-0. Although he concurred with the Commission's decision in this matter, Commissioner Mozelle Thompson issued a separate statement in which he voiced some concerns about the merger.

Copies of the Commission's Statement, and the separate statement of Commissioner Thompson, are available from the FTC's web site at http://www.ftc.gov and also from the FTC's Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580. The FTC works for the consumer to prevent fraudulent, deceptive and unfair business practices in the marketplace and to provide information to help consumers spot, stop and avoid them. To file a complaint, or to get free information on any of 150 consumer topics, call toll-free, 1-877-FTC-HELP (1-877-382-4357), or use the complaint form at http://www.ftc.gov. The FTC enters Internet, telemarketing, identity theft and other fraud-related complaints into Consumer Sentinel, a secure, online database available to hundreds of civil and criminal law enforcement agencies in the U.S. and abroad.

(FTC File No.: 011-0122)

Contact Information

Media Contact:
Howard Shapiro,
Office of Public Affairs
202-326-2176
Staff Contact:
Sean M. Royall or Michael E. Antalics
202-326-3663 or 202-326-2821